— Know what they know.
Not Investment Advice
Also trades as: DTC.CN (CNQ) · $vol 0M

DTCFF OTC

Defence Therapeutics Inc.
1W: -18.9% 1M: -22.8% 3M: -7.5% YTD: -50.2% 1Y: -45.0% 3Y: -87.1% 5Y: -94.8%
$0.28
+0.00 (+0.83%)
 
Weekly Expected Move ±10.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 35 · $21.2M mcap · 68M float · 0.012% daily turnover · Short 29% of daily vol

Balance Sheet Trends

Total Assets
$2M +246.0% ▲
5Y CAGR: -2.9%
Total Liabilities
$3M -28.4% ▼
5Y CAGR: +126.9%
Shareholders Equity
-$1M +72.1% ▲
Cash & Investments
$1M +2080.5% ▲
5Y CAGR: -8.0%
Total Debt
$2M -13.8% ▼
Net Debt
$272K -83.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$5M$507K$3M$57K$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$5M$507K$3M$57K$1M
Net Receivables$0$0$0$0$198K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$6M$674K$3M$214K$1M
Property, Plant & Equip.$0$0$59K$264K$188K
Goodwill & Intangibles$46K$46K$39K$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$46K$46K$98K$264K$188K
Total Assets$6M$720K$4M$478K$2M
— Liabilities —
Accounts Payable$114$980$192K$2M$0
Short-Term Debt$0$0$0$2M$2M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$9K$128K$29K$225K$1M
Total Current Liabilities$122K$1M$220K$4M$3M
Long-Term Debt$0$0$2M$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$2M$8K$0
Total Liabilities$122K$1M$2M$4M$3M
— Equity —
Common Stock$8M$9M$17M$19M$24M
Retained Earnings-$4M-$11M-$17M-$30M-$29M
Accumulated OCI$1M$794K$2M$0$4M
Total Stockholders Equity$5M-$388K$2M-$4M-$1M
Total Liabilities & Equity$6M$720K$4M$478K$2M
— Key Metrics —
Total Debt$0$0$2M$2M$2M
Net Debt-$5M-$507K-$1M$2M$272K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms